FEBUXOSTAT is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in patients with gout.
FEBUXOSTAT is not recommended for the treatment of asymptomatic hyperuricemia.
Other Services
Country
Account
Sign Out